Correlation Between Apogee Therapeutics, and Eshallgo

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Eshallgo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Eshallgo into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and Eshallgo Class A, you can compare the effects of market volatilities on Apogee Therapeutics, and Eshallgo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Eshallgo. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Eshallgo.

Diversification Opportunities for Apogee Therapeutics, and Eshallgo

-0.4

Correlation Coefficient

Apogee Therapeutics,  Eshallgo

Very good diversification

The 3 months correlation between Apogee and Eshallgo is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Eshallgo Class A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eshallgo Class A and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Eshallgo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eshallgo Class A has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Eshallgo go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Eshallgo

Given the investment horizon of 90 days Apogee Therapeutics, is expected to generate 19.44 times less return on investment than Eshallgo. But when comparing it to its historical volatility, Apogee Therapeutics, Common is 1.82 times less risky than Eshallgo. It trades about 0.02 of its potential returns per unit of risk. Eshallgo Class A is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  218.00  in Eshallgo Class A on September 7, 2024 and sell it today you would earn a total of  185.00  from holding Eshallgo Class A or generate 84.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  Eshallgo Class A

Apogee Therapeutics,

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Apogee Therapeutics, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Eshallgo Class A

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Eshallgo Class A are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Eshallgo displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Apogee Therapeutics, and Eshallgo

The main advantage of trading using opposite Apogee Therapeutics, and Eshallgo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Eshallgo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eshallgo will offset losses from the drop in Eshallgo's long position.

The idea behind Apogee Therapeutics, Common and Eshallgo Class A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.